Study Of The Core Competitiveness Of The Pharmaceutical Companies In Sichuan Province

Objective Sichuan province, as a great western province of China, have a good foundation in the pharmaceutical industry. However, in recent years, the pharmaceutical enterprises in Sichuan has slowed down, and the overall strength have declined in the country. How to establish the core competence of pharmaceutical enterprises in Sichuan in a fierce competition, and enhance their strength, has become an urgent solution. In this paper, the core competence of foreign enterprises and pharmaceutical enterprises in Sichuan has been analysised. And then, the pharmaceutical enterprise's core competence evaluation model has been constructed, and Sichuan Dikang enterprise has been evaluated. So it has significance to improve the core competence of pharmaceutical enterprise in Sichuan.Methods In this paper, the theoretical analysis and empirical analysis, comparative analysis and case analysis, quantitative analysis and qualitative analysis of a combination of methods. Based on theoretical studies, the article made more profound theoretical study to the core competence. Meanwhile, foreign companies to build the core competitive edge of the research, and to conduct analysis of Pfizer. Then, the article analyzes the status of pharmaceutical enterprises in Sichuan, and specificly analyzes of the comparative advantages and disadvantages aimed at the Chinese medicine, chemical medicines and biological pharmaceutical enterprises in the sub-sector. Also, the core competence evaluation model of pharmaceutical companies has been build , and to evaluate Chengdu DiKang Pharmaceutical Corporation. Based on comprehensive analysis and empirical research, the articles propose how to establish the core competence of pharmaceutical corporation in Sichuan.Content This paper is divided into five parts, each part of the major elements is: The first part from the core competence theoretical research, and analyse the theoretical development, definition, basic characteristics and competitive advantage, then study the characteristics and the core elements. The second part analyse the process of constructing the core competence of foreign pharmaceutical enterprises, and particularly study Pfizer's core competence, these are useful for the pharmaceutical enterprises in Sichuan. The third part of the analysis of the current situation of pharmaceutical enterprises in Sichuan, and were aimed at the Chinese medicine, chemical medicines, Biopharmaceutical Enterprises specific analysis, and research the advantages and disadvantages. The fourth part construct the evaluation model of enterprise's core competence, and analyse Sichuan DiKang Pharmaceutical Corporation. In the fifth part based on the comprehensive analysis and empirical research, the paper propose from the enterprise resources, technological innovation, market development, business management, and corporate culture, and these has important research value and significance to enhance the competence of pharmaceutical enterprises in Sichuan.Innovation Sichuan pharmaceutical innovation lies in the article against the specific sub-sector analysis, the conclusion is more practical significance. Meanwhile, the paper construct the enterprise's core competitiveness evaluation model, and study the pharmaceutical enterprises in Sichuan. Qualitative research papers completely different from the past, the combination of quantitative and qualitative analysis is more persuasive.Conclutions Sichuan pharmaceutical industry has a good foundation and resources, but there is still a considerable gap between the eastern pharmaceutical enterprises. So the core competence of pharmaceutical enterprise in Sichuan could be advanced from packing up enterprise resources, resulting in the ability in technological innovation, increasing market development efforts, improving enterprise management system, and building corporate culture.